Industry Research Reports

Home > Reports > Service & Software > Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-04-28

Pages: 138 Pages

Report ld: 3129134

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.

The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

North American market for Virtual Screening for Drug Discovery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Virtual Screening for Drug Discovery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Virtual Screening for Drug Discovery was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Virtual Screening for Drug Discovery include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

The Virtual Screening for Drug Discovery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Screening for Drug Discovery.

MARKET SEGMENTATION

By Company

MedChemExpress
TargetMol
OpenEye Scientific
Eurofins Discovery
Sygnature Discovery
Jubilant Biosys
Schrödinger, Inc.
Cresset Group
ComputaBio
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
CKTTDB
HitGen
WuXi AppTec
LeadBuilder
CSNpharm
ChemNavigator

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Hybrid Methods

Segment by Application

Pharmaceutical Company
Universities and Research Institutions
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Virtual Screening for Drug Discovery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Virtual Screening for Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Virtual Screening for Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Virtual Screening for Drug Discovery Product Introduction

1.2 Global Virtual Screening for Drug Discovery Market Size Forecast (2019-2030)

1.3 Virtual Screening for Drug Discovery Market Trends & Drivers

1.3.1 Virtual Screening for Drug Discovery Industry Trends

1.3.2 Virtual Screening for Drug Discovery Market Drivers & Opportunity

1.3.3 Virtual Screening for Drug Discovery Market Challenges

1.3.4 Virtual Screening for Drug Discovery Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Virtual Screening for Drug Discovery Players Revenue Ranking (2023)

2.2 Global Virtual Screening for Drug Discovery Revenue by Company (2019-2024)

2.3 Key Companies Virtual Screening for Drug Discovery Manufacturing Base Distribution and Headquarters

2.4 Key Companies Virtual Screening for Drug Discovery Product Offered

2.5 Key Companies Time to Begin Mass Production of Virtual Screening for Drug Discovery

2.6 Virtual Screening for Drug Discovery Market Competitive Analysis

2.6.1 Virtual Screening for Drug Discovery Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Virtual Screening for Drug Discovery Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Structure-based Virtual Screening (SBVS)

3.1.2 Ligand-based Virtual Screening (LBVS)

3.1.3 Hybrid Methods

3.2 Global Virtual Screening for Drug Discovery Sales Value by Type

3.2.1 Global Virtual Screening for Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Virtual Screening for Drug Discovery Sales Value, by Type (2019-2030)

3.2.3 Global Virtual Screening for Drug Discovery Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical Company

4.1.2 Universities and Research Institutions

4.1.3 Others

4.2 Global Virtual Screening for Drug Discovery Sales Value by Application

4.2.1 Global Virtual Screening for Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Virtual Screening for Drug Discovery Sales Value, by Application (2019-2030)

4.2.3 Global Virtual Screening for Drug Discovery Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Virtual Screening for Drug Discovery Sales Value by Region

5.1.1 Global Virtual Screening for Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Virtual Screening for Drug Discovery Sales Value by Region (2019-2024)

5.1.3 Global Virtual Screening for Drug Discovery Sales Value by Region (2025-2030)

5.1.4 Global Virtual Screening for Drug Discovery Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Virtual Screening for Drug Discovery Sales Value, 2019-2030

5.2.2 North America Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Virtual Screening for Drug Discovery Sales Value, 2019-2030

5.3.2 Europe Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Virtual Screening for Drug Discovery Sales Value, 2019-2030

5.4.2 Asia Pacific Virtual Screening for Drug Discovery Sales Value by Region (%), 2023 VS 2030

5.5 South America

5.5.1 South America Virtual Screening for Drug Discovery Sales Value, 2019-2030

5.5.2 South America Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Virtual Screening for Drug Discovery Sales Value, 2019-2030

5.6.2 Middle East & Africa Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Virtual Screening for Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.3 United States

6.3.1 United States Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.3.2 United States Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.4.2 Europe Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.5.2 China Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.5.3 China Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.6.2 Japan Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.7.2 South Korea Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.8.2 Southeast Asia Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Virtual Screening for Drug Discovery Sales Value, 2019-2030

6.9.2 India Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

6.9.3 India Virtual Screening for Drug Discovery Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 MedChemExpress

7.1.1 MedChemExpress Profile

7.1.2 MedChemExpress Main Business

7.1.3 MedChemExpress Virtual Screening for Drug Discovery Products, Services and Solutions

7.1.4 MedChemExpress Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.1.5 MedChemExpress Recent Developments

7.2 TargetMol

7.2.1 TargetMol Profile

7.2.2 TargetMol Main Business

7.2.3 TargetMol Virtual Screening for Drug Discovery Products, Services and Solutions

7.2.4 TargetMol Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.2.5 TargetMol Recent Developments

7.3 OpenEye Scientific

7.3.1 OpenEye Scientific Profile

7.3.2 OpenEye Scientific Main Business

7.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Products, Services and Solutions

7.3.4 OpenEye Scientific Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.3.5 OpenEye Scientific Recent Developments

7.4 Eurofins Discovery

7.4.1 Eurofins Discovery Profile

7.4.2 Eurofins Discovery Main Business

7.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Products, Services and Solutions

7.4.4 Eurofins Discovery Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.4.5 Eurofins Discovery Recent Developments

7.5 Sygnature Discovery

7.5.1 Sygnature Discovery Profile

7.5.2 Sygnature Discovery Main Business

7.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Products, Services and Solutions

7.5.4 Sygnature Discovery Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.5.5 Sygnature Discovery Recent Developments

7.6 Jubilant Biosys

7.6.1 Jubilant Biosys Profile

7.6.2 Jubilant Biosys Main Business

7.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Products, Services and Solutions

7.6.4 Jubilant Biosys Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.6.5 Jubilant Biosys Recent Developments

7.7 Schrödinger, Inc.

7.7.1 Schrödinger, Inc. Profile

7.7.2 Schrödinger, Inc. Main Business

7.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Products, Services and Solutions

7.7.4 Schrödinger, Inc. Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.7.5 Schrödinger, Inc. Recent Developments

7.8 Cresset Group

7.8.1 Cresset Group Profile

7.8.2 Cresset Group Main Business

7.8.3 Cresset Group Virtual Screening for Drug Discovery Products, Services and Solutions

7.8.4 Cresset Group Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.8.5 Cresset Group Recent Developments

7.9 ComputaBio

7.9.1 ComputaBio Profile

7.9.2 ComputaBio Main Business

7.9.3 ComputaBio Virtual Screening for Drug Discovery Products, Services and Solutions

7.9.4 ComputaBio Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.9.5 ComputaBio Recent Developments

7.10 Profacgen

7.10.1 Profacgen Profile

7.10.2 Profacgen Main Business

7.10.3 Profacgen Virtual Screening for Drug Discovery Products, Services and Solutions

7.10.4 Profacgen Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.10.5 Profacgen Recent Developments

7.11 CD ComputaBio

7.11.1 CD ComputaBio Profile

7.11.2 CD ComputaBio Main Business

7.11.3 CD ComputaBio Virtual Screening for Drug Discovery Products, Services and Solutions

7.11.4 CD ComputaBio Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.11.5 CD ComputaBio Recent Developments

7.12 Creative Biolabs

7.12.1 Creative Biolabs Profile

7.12.2 Creative Biolabs Main Business

7.12.3 Creative Biolabs Virtual Screening for Drug Discovery Products, Services and Solutions

7.12.4 Creative Biolabs Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.12.5 Creative Biolabs Recent Developments

7.13 BOC Sciences

7.13.1 BOC Sciences Profile

7.13.2 BOC Sciences Main Business

7.13.3 BOC Sciences Virtual Screening for Drug Discovery Products, Services and Solutions

7.13.4 BOC Sciences Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.13.5 BOC Sciences Recent Developments

7.14 CKTTDB

7.14.1 CKTTDB Profile

7.14.2 CKTTDB Main Business

7.14.3 CKTTDB Virtual Screening for Drug Discovery Products, Services and Solutions

7.14.4 CKTTDB Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.14.5 CKTTDB Recent Developments

7.15 HitGen

7.15.1 HitGen Profile

7.15.2 HitGen Main Business

7.15.3 HitGen Virtual Screening for Drug Discovery Products, Services and Solutions

7.15.4 HitGen Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.15.5 HitGen Recent Developments

7.16 WuXi AppTec

7.16.1 WuXi AppTec Profile

7.16.2 WuXi AppTec Main Business

7.16.3 WuXi AppTec Virtual Screening for Drug Discovery Products, Services and Solutions

7.16.4 WuXi AppTec Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.16.5 WuXi AppTec Recent Developments

7.17 LeadBuilder

7.17.1 LeadBuilder Profile

7.17.2 LeadBuilder Main Business

7.17.3 LeadBuilder Virtual Screening for Drug Discovery Products, Services and Solutions

7.17.4 LeadBuilder Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.17.5 LeadBuilder Recent Developments

7.18 CSNpharm

7.18.1 CSNpharm Profile

7.18.2 CSNpharm Main Business

7.18.3 CSNpharm Virtual Screening for Drug Discovery Products, Services and Solutions

7.18.4 CSNpharm Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.18.5 CSNpharm Recent Developments

7.19 ChemNavigator

7.19.1 ChemNavigator Profile

7.19.2 ChemNavigator Main Business

7.19.3 ChemNavigator Virtual Screening for Drug Discovery Products, Services and Solutions

7.19.4 ChemNavigator Virtual Screening for Drug Discovery Revenue (US$ Million) & (2019-2024)

7.19.5 ChemNavigator Recent Developments

8 Industry Chain Analysis

8.1 Virtual Screening for Drug Discovery Industrial Chain

8.2 Virtual Screening for Drug Discovery Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Virtual Screening for Drug Discovery Sales Model

8.5.2 Sales Channel

8.5.3 Virtual Screening for Drug Discovery Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Virtual Screening for Drug Discovery Market Trends

Table 2. Virtual Screening for Drug Discovery Market Drivers & Opportunity

Table 3. Virtual Screening for Drug Discovery Market Challenges

Table 4. Virtual Screening for Drug Discovery Market Restraints

Table 5. Global Virtual Screening for Drug Discovery Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Virtual Screening for Drug Discovery Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Virtual Screening for Drug Discovery Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Virtual Screening for Drug Discovery Product Type

Table 9. Key Companies Time to Begin Mass Production of Virtual Screening for Drug Discovery

Table 10. Global Virtual Screening for Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Virtual Screening for Drug Discovery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Virtual Screening for Drug Discovery Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Virtual Screening for Drug Discovery Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Virtual Screening for Drug Discovery Sales Market Share in Value by Type (2019-2024)

Table 17. Global Virtual Screening for Drug Discovery Sales Market Share in Value by Type (2025-2030)

Table 18. Global Virtual Screening for Drug Discovery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Virtual Screening for Drug Discovery Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Virtual Screening for Drug Discovery Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Virtual Screening for Drug Discovery Sales Market Share in Value by Application (2019-2024)

Table 22. Global Virtual Screening for Drug Discovery Sales Market Share in Value by Application (2025-2030)

Table 23. Global Virtual Screening for Drug Discovery Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)

Table 24. Global Virtual Screening for Drug Discovery Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Virtual Screening for Drug Discovery Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Virtual Screening for Drug Discovery Sales Value by Region (2019-2024) & (%)

Table 27. Global Virtual Screening for Drug Discovery Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Virtual Screening for Drug Discovery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Virtual Screening for Drug Discovery Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Virtual Screening for Drug Discovery Sales Value, (2025-2030) & (US$ Million)

Table 31. MedChemExpress Basic Information List

Table 32. MedChemExpress Description and Business Overview

Table 33. MedChemExpress Virtual Screening for Drug Discovery Products, Services and Solutions

Table 34. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of MedChemExpress (2019-2024)

Table 35. MedChemExpress Recent Developments

Table 36. TargetMol Basic Information List

Table 37. TargetMol Description and Business Overview

Table 38. TargetMol Virtual Screening for Drug Discovery Products, Services and Solutions

Table 39. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of TargetMol (2019-2024)

Table 40. TargetMol Recent Developments

Table 41. OpenEye Scientific Basic Information List

Table 42. OpenEye Scientific Description and Business Overview

Table 43. OpenEye Scientific Virtual Screening for Drug Discovery Products, Services and Solutions

Table 44. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of OpenEye Scientific (2019-2024)

Table 45. OpenEye Scientific Recent Developments

Table 46. Eurofins Discovery Basic Information List

Table 47. Eurofins Discovery Description and Business Overview

Table 48. Eurofins Discovery Virtual Screening for Drug Discovery Products, Services and Solutions

Table 49. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Eurofins Discovery (2019-2024)

Table 50. Eurofins Discovery Recent Developments

Table 51. Sygnature Discovery Basic Information List

Table 52. Sygnature Discovery Description and Business Overview

Table 53. Sygnature Discovery Virtual Screening for Drug Discovery Products, Services and Solutions

Table 54. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Sygnature Discovery (2019-2024)

Table 55. Sygnature Discovery Recent Developments

Table 56. Jubilant Biosys Basic Information List

Table 57. Jubilant Biosys Description and Business Overview

Table 58. Jubilant Biosys Virtual Screening for Drug Discovery Products, Services and Solutions

Table 59. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Jubilant Biosys (2019-2024)

Table 60. Jubilant Biosys Recent Developments

Table 61. Schrödinger, Inc. Basic Information List

Table 62. Schrödinger, Inc. Description and Business Overview

Table 63. Schrödinger, Inc. Virtual Screening for Drug Discovery Products, Services and Solutions

Table 64. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Schrödinger, Inc. (2019-2024)

Table 65. Schrödinger, Inc. Recent Developments

Table 66. Cresset Group Basic Information List

Table 67. Cresset Group Description and Business Overview

Table 68. Cresset Group Virtual Screening for Drug Discovery Products, Services and Solutions

Table 69. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Cresset Group (2019-2024)

Table 70. Cresset Group Recent Developments

Table 71. ComputaBio Basic Information List

Table 72. ComputaBio Description and Business Overview

Table 73. ComputaBio Virtual Screening for Drug Discovery Products, Services and Solutions

Table 74. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of ComputaBio (2019-2024)

Table 75. ComputaBio Recent Developments

Table 76. Profacgen Basic Information List

Table 77. Profacgen Description and Business Overview

Table 78. Profacgen Virtual Screening for Drug Discovery Products, Services and Solutions

Table 79. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Profacgen (2019-2024)

Table 80. Profacgen Recent Developments

Table 81. CD ComputaBio Basic Information List

Table 82. CD ComputaBio Description and Business Overview

Table 83. CD ComputaBio Virtual Screening for Drug Discovery Products, Services and Solutions

Table 84. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of CD ComputaBio (2019-2024)

Table 85. CD ComputaBio Recent Developments

Table 86. Creative Biolabs Basic Information List

Table 87. Creative Biolabs Description and Business Overview

Table 88. Creative Biolabs Virtual Screening for Drug Discovery Products, Services and Solutions

Table 89. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of Creative Biolabs (2019-2024)

Table 90. Creative Biolabs Recent Developments

Table 91. BOC Sciences Basic Information List

Table 92. BOC Sciences Description and Business Overview

Table 93. BOC Sciences Virtual Screening for Drug Discovery Products, Services and Solutions

Table 94. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of BOC Sciences (2019-2024)

Table 95. BOC Sciences Recent Developments

Table 96. CKTTDB Basic Information List

Table 97. CKTTDB Description and Business Overview

Table 98. CKTTDB Virtual Screening for Drug Discovery Products, Services and Solutions

Table 99. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of CKTTDB (2019-2024)

Table 100. CKTTDB Recent Developments

Table 101. HitGen Basic Information List

Table 102. HitGen Description and Business Overview

Table 103. HitGen Virtual Screening for Drug Discovery Products, Services and Solutions

Table 104. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of HitGen (2019-2024)

Table 105. HitGen Recent Developments

Table 106. WuXi AppTec Basic Information List

Table 107. WuXi AppTec Description and Business Overview

Table 108. WuXi AppTec Virtual Screening for Drug Discovery Products, Services and Solutions

Table 109. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of WuXi AppTec (2019-2024)

Table 110. WuXi AppTec Recent Developments

Table 111. LeadBuilder Basic Information List

Table 112. LeadBuilder Description and Business Overview

Table 113. LeadBuilder Virtual Screening for Drug Discovery Products, Services and Solutions

Table 114. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of LeadBuilder (2019-2024)

Table 115. LeadBuilder Recent Developments

Table 116. CSNpharm Basic Information List

Table 117. CSNpharm Description and Business Overview

Table 118. CSNpharm Virtual Screening for Drug Discovery Products, Services and Solutions

Table 119. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of CSNpharm (2019-2024)

Table 120. CSNpharm Recent Developments

Table 121. ChemNavigator Basic Information List

Table 122. ChemNavigator Description and Business Overview

Table 123. ChemNavigator Virtual Screening for Drug Discovery Products, Services and Solutions

Table 124. Revenue (US$ Million) in Virtual Screening for Drug Discovery Business of ChemNavigator (2019-2024)

Table 125. ChemNavigator Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Virtual Screening for Drug Discovery Downstream Customers

Table 129. Virtual Screening for Drug Discovery Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Virtual Screening for Drug Discovery Product Picture

Figure 2. Global Virtual Screening for Drug Discovery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Virtual Screening for Drug Discovery Sales Value (2019-2030) & (US$ Million)

Figure 4. Virtual Screening for Drug Discovery Report Years Considered

Figure 5. Global Virtual Screening for Drug Discovery Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Virtual Screening for Drug Discovery Revenue in 2023

Figure 7. Virtual Screening for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Structure-based Virtual Screening (SBVS) Picture

Figure 9. Ligand-based Virtual Screening (LBVS) Picture

Figure 10. Hybrid Methods Picture

Figure 11. Global Virtual Screening for Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Virtual Screening for Drug Discovery Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Pharmaceutical Company

Figure 14. Product Picture of Universities and Research Institutions

Figure 15. Product Picture of Others

Figure 16. Global Virtual Screening for Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Virtual Screening for Drug Discovery Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Virtual Screening for Drug Discovery Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 21. Europe Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Virtual Screening for Drug Discovery Sales Value by Region (%), 2023 VS 2030

Figure 24. South America Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 25. South America Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Virtual Screening for Drug Discovery Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Virtual Screening for Drug Discovery Sales Value (%), (2019-2030)

Figure 29. United States Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 35. China Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 37. China Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 47. India Virtual Screening for Drug Discovery Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Virtual Screening for Drug Discovery Sales Value by Type (%), 2023 VS 2030

Figure 49. India Virtual Screening for Drug Discovery Sales Value by Application (%), 2023 VS 2030

Figure 50. Virtual Screening for Drug Discovery Industrial Chain

Figure 51. Virtual Screening for Drug Discovery Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Virtual Screening for Drug Discovery market? zhanKai

The top companies in the global Virtual Screening for Drug Discovery market are MedChemExpress、TargetMol、OpenEye Scientific.

Related Reports

Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 160
USD 4900.00
(Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virtual Screening for Drug Discovery market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 105
USD 4250.00
(Single User License)
Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 139
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 127
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 105
USD 4250.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 156
USD 4900.00
(Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 121
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 99
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 95
USD 2900.00
(Single User License)
Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 121
USD 4350.00
(Single User License)

Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 160
USD 4900.00 (Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Virtual Screening for Drug Discovery market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 105
USD 4250.00 (Single User License)
Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 139
USD 3950.00 (Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 127
USD 2900.00 (Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 105
USD 4250.00 (Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 156
USD 4900.00 (Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 121
USD 3950.00 (Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 99
USD 2900.00 (Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 95
USD 2900.00 (Single User License)
Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 121
USD 4350.00 (Single User License)